Tapewire

NYSE · USD

CI

Cigna Group

Export transactions ↓
Tapewire entity
550
SEC CIK
0001739940
Parsed reports
653

Last 12 months

Inside the activity.

1 purchase rows · 19 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202602
Apr 202600
May 2026013
Jun 202601
Jul 202600
Aug 202602
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2024 Filed Mar 5, 2024 22:43 UTC
Cordani DavidDirector · Chairman & CEO
GrantCommon Stock, $.01 Par Value 35,946 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-003707 · doc4.xml · nonDerivative · entry 1

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 382,656

F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:43 UTC
BRAILER DAVID JEVP & Chief Health Officer
Tax withholdingCommon Stock, $.01 Par Value 1,099 $333.36 $366,362.64
Disclosure

SEC source: 0001225208-24-003706 · doc4.xml · nonDerivative · entry 3

BRAILER DAVID J · CIK 0001222879 · EVP & Chief Health Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,332

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:43 UTC
BRAILER DAVID JEVP & Chief Health Officer
Tax withholdingCommon Stock, $.01 Par Value 412 $333.36 $137,344.32
Disclosure

SEC source: 0001225208-24-003706 · doc4.xml · nonDerivative · entry 2

BRAILER DAVID J · CIK 0001222879 · EVP & Chief Health Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,431

F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:43 UTC
BRAILER DAVID JEVP & Chief Health Officer
GrantCommon Stock, $.01 Par Value 2,780 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-003706 · doc4.xml · nonDerivative · entry 1

BRAILER DAVID J · CIK 0001222879 · EVP & Chief Health Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,843

F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:43 UTC
Evanko Brian CSee Remarks
Tax withholdingCommon Stock, $.01 Par Value 3,860 $333.36 $1,286,769.60
Disclosure

SEC source: 0001225208-24-003709 · doc4.xml · nonDerivative · entry 3

Evanko Brian C · CIK 0001722909 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,923

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:43 UTC
Evanko Brian CSee Remarks
Tax withholdingCommon Stock, $.01 Par Value 1,575 $333.36 $525,042.00
Disclosure

SEC source: 0001225208-24-003709 · doc4.xml · nonDerivative · entry 2

Evanko Brian C · CIK 0001722909 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,783

F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:43 UTC
Evanko Brian CSee Remarks
GrantCommon Stock, $.01 Par Value 8,329 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-003709 · doc4.xml · nonDerivative · entry 1

Evanko Brian C · CIK 0001722909 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,358

F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:43 UTC
Triplett Michael WSpecial Advisor
Tax withholdingCommon Stock, $.01 Par Value 2,492 $333.36 $830,733.12
Disclosure

SEC source: 0001225208-24-003705 · doc4.xml · nonDerivative · entry 3

Triplett Michael W · CIK 0001698840 · Special Advisor

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,405

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:43 UTC
Triplett Michael WSpecial Advisor
Tax withholdingCommon Stock, $.01 Par Value 749 $333.36 $249,686.64
Disclosure

SEC source: 0001225208-24-003705 · doc4.xml · nonDerivative · entry 2

Triplett Michael W · CIK 0001698840 · Special Advisor

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,897

F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:43 UTC
Triplett Michael WSpecial Advisor
GrantCommon Stock, $.01 Par Value 5,702 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-003705 · doc4.xml · nonDerivative · entry 1

Triplett Michael W · CIK 0001698840 · Special Advisor

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,646

F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:43 UTC
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
Tax withholdingCommon Stock, $.01 Par Value 532 $333.36 $177,347.52
Disclosure

SEC source: 0001225208-24-003704 · doc4.xml · nonDerivative · entry 3

Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,586.324

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:43 UTC
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
Tax withholdingCommon Stock, $.01 Par Value 224 $333.36 $74,672.64
Disclosure

SEC source: 0001225208-24-003704 · doc4.xml · nonDerivative · entry 2

Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,118.324

F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:43 UTC
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
GrantCommon Stock, $.01 Par Value 1,240 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-003704 · doc4.xml · nonDerivative · entry 1

Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,342.324

F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 29, 2024 Filed Mar 2, 2024 00:44 UTC GrantPhantom Stock Units · Derivative 117.5106 $336.14 $39,500.01
Disclosure

SEC source: 0001225208-24-003412 · doc4.xml · derivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,763.9471

Underlying: Common Stock, $.01 Par Value · 117.5106 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F2 · balance_after: Includes 31.5111 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan.

Read SEC document
February 29, 2024 Filed Mar 2, 2024 00:44 UTC GrantPhantom Stock Units · Derivative 89.2485 $336.14 $29,999.99
Disclosure

SEC source: 0001225208-24-003411 · doc4.xml · derivative · entry 1

Kurian George · CIK 0001586813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 991.2836

Underlying: Common Stock, $.01 Par Value · 89.2485 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F2 · balance_after: Includes 3.7173 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan.

Read SEC document
February 28, 2024 Filed Mar 2, 2024 00:44 UTC
Triplett Michael WSpecial Advisor
GrantEmployee Stock Option (Right to Buy) · Derivative 6,226 $0.00 Strike: $336.48 $0.00
Disclosure

SEC source: 0001225208-24-003419 · doc4.xml · derivative · entry 3

Triplett Michael W · CIK 0001698840 · Special Advisor

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,226

Underlying: Common Stock, $.01 Par Value · 6,226 shares

Expires 2034-02-28

F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2025.

Read SEC document
February 28, 2024 Filed Mar 2, 2024 00:44 UTC
Triplett Michael WSpecial Advisor
GrantCommon Stock, $.01 Par Value 1,709 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-003419 · doc4.xml · nonDerivative · entry 1

Triplett Michael W · CIK 0001698840 · Special Advisor

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,944

F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2025.

Read SEC document
February 28, 2024 Filed Mar 2, 2024 00:44 UTC
Palmer Eric PSee Remarks
GrantEmployee Stock Option (Right to Buy) · Derivative 18,677 $0.00 Strike: $336.48 $0.00
Disclosure

SEC source: 0001225208-24-003418 · doc4.xml · derivative · entry 5

Palmer Eric P · CIK 0001710190 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,677

Underlying: Common Stock, $.01 Par Value · 18,677 shares

Expires 2034-02-28

F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2025.

Read SEC document
February 28, 2024 Filed Mar 2, 2024 00:44 UTC
Palmer Eric PSee Remarks
GrantCommon Stock, $.01 Par Value 5,127 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-003418 · doc4.xml · nonDerivative · entry 1

Palmer Eric P · CIK 0001710190 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,169

F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2025.

Read SEC document
February 28, 2024 Filed Mar 2, 2024 00:44 UTC
Jones Nicole SSee Remarks
GrantEmployee Stock Option (Right to Buy) · Derivative 9,677 $0.00 Strike: $336.48 $0.00
Disclosure

SEC source: 0001225208-24-003417 · doc4.xml · derivative · entry 3

Jones Nicole S · CIK 0001492663 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,677

Underlying: Common Stock, $.01 Par Value · 9,677 shares

Expires 2034-02-28

F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2025.

Read SEC document
February 28, 2024 Filed Mar 2, 2024 00:44 UTC
Jones Nicole SSee Remarks
GrantCommon Stock, $.01 Par Value 2,657 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-003417 · doc4.xml · nonDerivative · entry 1

Jones Nicole S · CIK 0001492663 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,726

F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2025.

Read SEC document
February 28, 2024 Filed Mar 2, 2024 00:44 UTC
Evanko Brian CSee Remarks
GrantEmployee Stock Option (Right to Buy) · Derivative 18,677 $0.00 Strike: $336.48 $0.00
Disclosure

SEC source: 0001225208-24-003416 · doc4.xml · derivative · entry 3

Evanko Brian C · CIK 0001722909 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,677

Underlying: Common Stock, $.01 Par Value · 18,677 shares

Expires 2034-02-28

F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2025.

Read SEC document
February 28, 2024 Filed Mar 2, 2024 00:44 UTC
Evanko Brian CSee Remarks
GrantCommon Stock, $.01 Par Value 5,127 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-003416 · doc4.xml · nonDerivative · entry 1

Evanko Brian C · CIK 0001722909 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,029

F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2025.

Read SEC document
February 28, 2024 Filed Mar 2, 2024 00:44 UTC
Cordani DavidDirector · Chairman & CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 36,162 $0.00 Strike: $336.48 $0.00
Disclosure

SEC source: 0001225208-24-003415 · doc4.xml · derivative · entry 5

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,162

Underlying: Common Stock, $.01 Par Value · 36,162 shares

Expires 2034-02-28

F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2025.

Read SEC document
February 28, 2024 Filed Mar 2, 2024 00:44 UTC
Cordani DavidDirector · Chairman & CEO
GrantCommon Stock, $.01 Par Value 9,927 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-003415 · doc4.xml · nonDerivative · entry 1

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 346,710

F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2025.

Read SEC document
February 28, 2024 Filed Mar 2, 2024 00:44 UTC
BRAILER DAVID JEVP & Chief Health Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 11,369 $0.00 Strike: $336.48 $0.00
Disclosure

SEC source: 0001225208-24-003414 · doc4.xml · derivative · entry 2

BRAILER DAVID J · CIK 0001222879 · EVP & Chief Health Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,369

Underlying: Common Stock, $.01 Par Value · 11,369 shares

Expires 2034-02-28

F2 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2025.

Read SEC document
February 28, 2024 Filed Mar 2, 2024 00:44 UTC
BRAILER DAVID JEVP & Chief Health Officer
GrantCommon Stock, $.01 Par Value 3,121 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-003414 · doc4.xml · nonDerivative · entry 1

BRAILER DAVID J · CIK 0001222879 · EVP & Chief Health Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,063

F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2025.

Read SEC document
February 28, 2024 Filed Mar 2, 2024 00:44 UTC
Eder Noelle KSee Remarks
GrantEmployee Stock Option (Right to Buy) · Derivative 9,677 $0.00 Strike: $336.48 $0.00
Disclosure

SEC source: 0001225208-24-003413 · doc4.xml · derivative · entry 3

Eder Noelle K · CIK 0001691704 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,677

Underlying: Common Stock, $.01 Par Value · 9,677 shares

Expires 2034-02-28

F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2025.

Read SEC document
February 28, 2024 Filed Mar 2, 2024 00:44 UTC
Eder Noelle KSee Remarks
GrantCommon Stock, $.01 Par Value 2,657 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-003413 · doc4.xml · nonDerivative · entry 1

Eder Noelle K · CIK 0001691704 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,581

F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2025.

Read SEC document
February 27, 2024 Filed Feb 27, 2024 22:48 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 2,000 $0.00 Strike: $139.22 $0.00
Disclosure

SEC source: 0001225208-24-003131 · doc4.xml · derivative · entry 14

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,429

Underlying: Common Stock, $.01 Par Value · 2,000 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.

F7 · derivative.exercise_date: This option was granted on March 1, 2016. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

Read SEC document
February 27, 2024 Filed Feb 27, 2024 22:48 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 2,000 $345.04 $690,075.00
Disclosure

SEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 8

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 336,783

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.

F5 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $345 to $345.095 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 27, 2024 Filed Feb 27, 2024 22:48 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionCommon Stock, $.01 Par Value 2,000 $139.22 $278,440.00
Disclosure

SEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 7

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 338,783

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.

Read SEC document
February 26, 2024 Filed Feb 27, 2024 22:48 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 10,453 $0.00 Strike: $139.22 $0.00
Disclosure

SEC source: 0001225208-24-003131 · doc4.xml · derivative · entry 13

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 78,429

Underlying: Common Stock, $.01 Par Value · 10,453 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.

F7 · derivative.exercise_date: This option was granted on March 1, 2016. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

Read SEC document
February 26, 2024 Filed Feb 27, 2024 22:48 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 6,829 $345.34 $2,358,298.18
Disclosure

SEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 6

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 336,783

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.

F4 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $345.00 to $345.98 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 26, 2024 Filed Feb 27, 2024 22:48 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 3,524 $346.38 $1,220,640.65
Disclosure

SEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 5

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 343,612

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.

F3 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $346.02 to $347.01 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 26, 2024 Filed Feb 27, 2024 22:48 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 100 $347.14 $34,713.50
Disclosure

SEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 4

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 347,136

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.

Read SEC document
February 26, 2024 Filed Feb 27, 2024 22:48 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionCommon Stock, $.01 Par Value 10,453 $139.22 $1,455,266.66
Disclosure

SEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 3

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 347,236

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.

Read SEC document
February 23, 2024 Filed Feb 27, 2024 22:48 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 6,319 $0.00 Strike: $139.22 $0.00
Disclosure

SEC source: 0001225208-24-003131 · doc4.xml · derivative · entry 12

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,882

Underlying: Common Stock, $.01 Par Value · 6,319 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.

F7 · derivative.exercise_date: This option was granted on March 1, 2016. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

Read SEC document
February 23, 2024 Filed Feb 27, 2024 22:48 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 6,319 $345.24 $2,181,592.41
Disclosure

SEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 2

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 336,783

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.

F2 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $345.00 to $345.59 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 23, 2024 Filed Feb 27, 2024 22:48 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionCommon Stock, $.01 Par Value 6,319 $139.22 $879,731.18
Disclosure

SEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 1

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 343,102

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.

Read SEC document
February 16, 2024 Filed Feb 20, 2024 22:57 UTC GiftCommon Stock, $.01 Par Value 3,376 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002542 · doc4.xml · nonDerivative · entry 1

DeLaney William J III · CIK 0001384151 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,000

F1 · balance_after: Total holdings were increased by one share of common stock due to an error on the Form 4 report that was filed on November 10, 2022.

Read SEC document
February 15, 2024 Filed Feb 15, 2024 22:30 UTC
Palmer Eric PSee Remarks
GiftCommon Stock, $.01 Par Value 312 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002196 · doc4.xml · nonDerivative · entry 6

Palmer Eric P · CIK 0001710190 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,437

Read SEC document
February 15, 2024 Filed Feb 15, 2024 22:30 UTC
Palmer Eric PSee Remarks
GiftCommon Stock, $.01 Par Value 312 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002196 · doc4.xml · nonDerivative · entry 5

Palmer Eric P · CIK 0001710190 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,042

Read SEC document
February 15, 2024 Filed Feb 15, 2024 22:30 UTC
Palmer Eric PSee Remarks
GiftCommon Stock, $.01 Par Value 200 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002196 · doc4.xml · nonDerivative · entry 4

Palmer Eric P · CIK 0001710190 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,354

Read SEC document
February 14, 2024 Filed Feb 15, 2024 22:30 UTC
Palmer Eric PSee Remarks
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 905 $0.00 Strike: $149.14 $0.00
Disclosure

SEC source: 0001225208-24-002196 · doc4.xml · derivative · entry 10

Palmer Eric P · CIK 0001710190 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.01 Par Value · 905 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Read SEC document
February 14, 2024 Filed Feb 15, 2024 22:30 UTC
Palmer Eric PSee Remarks
Exercise / conversionCommon Stock, $.01 Par Value 905 $149.14 $134,967.18
Disclosure

SEC source: 0001225208-24-002196 · doc4.xml · nonDerivative · entry 3

Palmer Eric P · CIK 0001710190 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,554

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Read SEC document
February 13, 2024 Filed Feb 13, 2024 22:27 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 7,462 $0.00 Strike: $139.22 $0.00
Disclosure

SEC source: 0001225208-24-001958 · doc4.xml · derivative · entry 13

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,201

Underlying: Common Stock, $.01 Par Value · 7,462 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.

F8 · derivative.exercise_date: This option was granted on March 1, 2016. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

Read SEC document
February 13, 2024 Filed Feb 13, 2024 22:27 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionCommon Stock, $.01 Par Value 7,462 $139.22 $1,038,859.64
Disclosure

SEC source: 0001225208-24-001958 · doc4.xml · nonDerivative · entry 7

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 336,783

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 22:30 UTC
Palmer Eric PSee Remarks
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 5,168 $0.00 Strike: $149.14 $0.00
Disclosure

SEC source: 0001225208-24-002196 · doc4.xml · derivative · entry 9

Palmer Eric P · CIK 0001710190 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 905

Underlying: Common Stock, $.01 Par Value · 5,168 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Read SEC document
February 13, 2024 Filed Feb 15, 2024 22:30 UTC
Palmer Eric PSee Remarks
SaleCommon Stock, $.01 Par Value 6,083 $340.00 $2,068,220.00
Disclosure

SEC source: 0001225208-24-002196 · doc4.xml · nonDerivative · entry 2

Palmer Eric P · CIK 0001710190 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,649

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.